Showing results (131-140 of 1,337) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|February 23, 2023
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastomaBenedito A Carneiro, Kyriakos P Papadopoulos, John H Strickler, et al.
Neuro-Oncology Advances|August 22, 2022
An affinity for brainstem microglia in pediatric high-grade gliomas of brainstem originLiat Peretz Zats, Labiba Ahmad, Natania Casden, et al.
Neuro-Oncology Advances|August 22, 2022
Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1Mi-Yeon Jung, Abudumijiti Aibaidula, Desmond A Brown, et al.
Neuro-Oncology Advances|March 27, 2023
Tumor microenvironment in glioblastoma: Current and emerging conceptsPratibha Sharma, Ashley Aaroe, Jiyong Liang, et al.
Neuro-Oncology Advances|May 5, 2021
Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adultsJianling Ji, Kristiyana Kaneva, Matthew C Hiemenz, et al.
Neuro-Oncology Advances|May 7, 2021
Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer DatabaseTiffany R Hodges, Collin M Labak, Uma V Mahajan, et al.
Neuro-Oncology Advances|May 7, 2021
Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute studyAnna R Damato, Jingqin Luo, Ruth G N Katumba, et al.
Neuro-Oncology Advances|September 6, 2021
Erratum to: Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed diseaseShervin Taslimi, Vincent C Ye, Gelareh Zadeh
Neuro-Oncology Advances|August 16, 2021
Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemicFernando Lozano-Sanchez, Renata Ursu, Anna Luisa Di-Stefano, et al.
Neuro-Oncology Advances|August 19, 2021
Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysisJames M Snyder, Raymond Y Huang, Harrison Bai, et al.
Pageof 134